ATI RN · Obstetrics and Pediatrics · Pediatric Clinical Nurse Specialist Exam Questions

Option A: B-Thalassemia is associated with microcytosis due to ineffective erythropoiesis and abnormal hemoglobin synthesis, leading to smaller red blood cells. This condition results in a characteristic low mean corpuscular volume (MCV) and is a common cause of microcytic anemia, particularly in certain populations.

Option B: Immune hemolytic anemia typically presents with normocytic anemia due to the destruction of red blood cells rather than a reduction in size, thus not causing microcytosis.

Option C: Hypothyroidism can lead to anemia, but it usually presents as normocytic or macrocytic rather than microcytic, as the underlying mechanism does not primarily affect red blood cell size.

Option D: Sickle cell anemia is characterized by the presence of sickle-shaped red blood cells and normocytic anemia, not microcytosis, as the red blood cells are typically of normal size despite their abnormal shape.

Takeaways: Microcytic anemia is primarily associated with conditions like B-Thalassemia, which involves smaller red blood cells due to ineffective erythropoiesis, highlighting the importance of understanding the types of anemia for accurate diagnosis and management.

Option B: Eosinophil is the main effector cell in bronchial asthma, playing a crucial role in the inflammatory response and airway hyperreactivity associated with this condition. Eosinophils contribute to tissue damage and the exacerbation of asthma symptoms through the release of inflammatory mediators and cytokines.

Option A: TH1 immune response predominates in other conditions, such as intracellular infections, while asthma is characterized by a TH2 response, which is associated with eosinophilic inflammation.

Option C: Increased serum IgA levels are not typically associated with asthma; rather, IgE is the immunoglobulin primarily involved in allergic responses and asthma pathophysiology.

Option D: While viral infections can exacerbate asthma, they are not the main cause of the condition. Asthma is primarily driven by a combination of genetic predisposition and environmental factors, including allergens and irritants.

Takeaways: Understanding that eosinophils are the main effector cells in asthma highlights the importance of targeting these cells in treatment strategies, especially for airway obstruction and ventilation management in patients with asthma.

Option D: Hyperkalemia does not typically result from alkali therapy in the treatment of metabolic acidosis in respiratory distress syndrome (RDS). Instead, alkali therapy can lead to a decrease in serum potassium levels due to shifts in potassium distribution and renal excretion. Therefore, hyperkalemia is not a common consequence of this treatment.

Option A: Skin slough from infiltration can occur due to the local effects of alkali solutions if they extravasate, causing tissue damage. This is a recognized risk associated with intravenous administration of alkali therapy.

Option B: Increased serum osmolarity is a potential effect of alkali therapy, particularly if large volumes of hypertonic solutions are administered, leading to osmotic shifts and changes in serum osmolarity.

Option C: Hypernatremia may occur as a result of administering sodium bicarbonate, which can increase serum sodium levels, especially if fluid balance is not carefully monitored during treatment.

Takeaways: Alkali therapy for metabolic acidosis can lead to complications such as skin slough, increased serum osmolarity, and hypernatremia, but it does not typically cause hyperkalemia, emphasizing the need for careful monitoring during treatment for metabolic acidosis in neonates to prevent adverse effects.

Option C: Hyperventilation is the compensatory mechanism that occurs in response to bicarbonate loss in urine, as it helps to increase the elimination of carbon dioxide, thereby raising blood pH towards normal levels. This respiratory compensation is crucial in maintaining acid-base balance when bicarbonate, a key buffer, is diminished.

Option A: Extracellular shift of potassium does not directly address the acid-base balance related to bicarbonate loss; rather, it pertains to potassium homeostasis and its movement in response to various metabolic states.

Option B: Hyperchloremia may occur in certain conditions but does not serve as a compensatory mechanism for bicarbonate loss; it reflects an increase in chloride levels rather than a direct response to maintain pH.

Option D: Loss of organic acid in urine does not contribute to compensatory mechanisms for bicarbonate loss; instead, it may lead to metabolic disturbances that further complicate acid-base balance.

Takeaways: Understanding the compensatory mechanism of hyperventilation is essential for managing acid-base disorders, as it plays a vital role in maintaining pH balance when bicarbonate levels are compromised, requiring effective respiratory assessment and intervention in clinical practice.

Option C: Thrombin time is not a screening test for a child with a bleeding tendency. It specifically assesses the conversion of fibrinogen to fibrin and is used to evaluate the common pathway of coagulation, rather than the initial bleeding risk.

Option A: Clotting time measures the time it takes for blood to clot and can indicate bleeding disorders, making it relevant for screening.

Option B: Bleeding time evaluates the function of platelets and the vascular response, which is crucial in assessing bleeding tendencies.

Option D: Partial thromboplastin time assesses the intrinsic and common pathways of coagulation, providing important information about bleeding risks.

Takeaways: Understanding the specific roles of coagulation tests is essential, as thrombin time does not serve as a screening tool for bleeding tendencies, while tests like bleeding time and partial thromboplastin time are critical for evaluating hemostatic function in children.